Cargando…
Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes
Genetic testing for germline mutations in BRCA1/2 of patients with breast cancer (BC) is part of routine patient care. However, BRCA1/2 mutations account only for a fraction of familial BC. A custom panel of 22 gene sequencing was performed on each patient. Among the 481 female patients, 135 patient...
Autores principales: | Wang, Jiayu, Li, Weiwei, Shi, Yujian, Huang, Yan, Sun, Tao, Tang, Lili, Lu, Qing, Lei, Qiumo, Liao, Ning, Jin, Feng, Li, Hui, Huang, Tao, Qian, Jun, Pang, Danmei, Wang, Shusen, Fan, Peizhi, Wu, Xinhong, Lin, Ying, Qin, Haiyan, Xu, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536923/ https://www.ncbi.nlm.nih.gov/pubmed/30982232 http://dx.doi.org/10.1002/cam4.2093 |
Ejemplares similares
-
Development of a prognostic model based on an immunogenomic landscape analysis of medulloblastoma
por: Guo, Yuduo, et al.
Publicado: (2021) -
Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study
por: Guo, Fengzhu, et al.
Publicado: (2021) -
The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021) -
MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation
por: Tang, Qisheng, et al.
Publicado: (2020) -
High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients
por: Chang, Boyang, et al.
Publicado: (2018)